CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for LeMaitre Vascular Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

LeMaitre Vascular Inc
63 2nd Ave
Phone: (781) 221-2266p:781 221-2266 BURLINGTON, MA  01803-4413  United States Ticker: LMATLMAT

Business Summary
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer George W.LeMaitre 58 7/24/2007 1/1/1992
President, Director David B.Roberts 58 7/24/2007 1/1/1997
Chief Financial Officer, Director Joseph P.Pellegrino 58 10/24/2016 1/1/2005
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Restore Flow Allografts, LLC 912 Northwest Highway Fox River Grove IL United States

Business Names
Business Name
Bio Nova
Cardial
Cardial SAS
23 additional Business Names available in full report.

General Information
Number of Employees: 614 (As of 12/31/2023)
Outstanding Shares: 22,337,216 (As of 2/27/2024)
Shareholders: 144
Stock Exchange: NASD
Federal Tax Id: 042825458
Fax Number: (781) 425-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024